MedTrace Logo

Optical Coherence Tomography of the Saphenous Vein Graft

NCT05129228 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 760

Last updated 2022-05-05

No results posted yet for this study

Summary

OCTOCAB is a prospective, randomized (1:1), single-center trial. The purpose of this study is to determine whether intravascular optical coherence tomography (OCT) guided saphenous vein grafting in coronary artery bypass surgery will reduce the rate of early vein graft failure (VGF).

Conditions

  • Coronary Bypass Graft Stenosis

Interventions

DEVICE

OCT-guided saphenous vein CABG

OCT examination of harvested saphenous vein conduits will indicate pathology. Under the surgeon's discretion the conduit segments with pathology will not be grafted.

Sponsors & Collaborators

  • St. Francis Hospital, New York

    lead OTHER

Principal Investigators

  • Ziad A. Ali, MD,DPhil · Saint Francis Hospital

  • Edward F. Lundy, MD, PhD · Saint Francis Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-04
Primary Completion
2024-04-04
Completion
2026-04-04
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05129228 on ClinicalTrials.gov